DOENÇAS CRÔNICAS E A BAIXA ADESÃO AO TRATAMENTO FARMACOLÓGICO
Autor(a) principal: | |
---|---|
Data de Publicação: | 2023 |
Outros Autores: | , , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Brazilian Journal of Implantology and Health Sciences |
Texto Completo: | https://bjihs.emnuvens.com.br/bjihs/article/view/840 |
Resumo: | Chronic diseases represent a significant global health challenge, characterized by their long duration and continuous impact on quality of life. Low adherence to pharmacological treatment is a recurring problem in this context, affecting therapeutic efficacy and disease progression. This lack of adherence can result from several factors, including complexity of the therapeutic regimen, medication side effects, costs, implications and individual perceptions, forgetfulness, or lack of understanding about the importance of treatment. The effects of low adherence are significant, leading to preventable complications, frequent hospitalizations and an increased burden of morbidity and mortality. Strategies to improve adherence to pharmacological treatment, educational interventions, simplification of medication regimens, use of reminders, social support, and regular monitoring by health professionals. The use of technology, such as apps and electronic devices, has also been shown to be helpful in improving adherence. It is essential that there is a multidisciplinary approach to address low adherence to treatment, involving doctors, pharmacists, psychologists, and other health professionals. Furthermore, creating a supportive environment that considers patients' individual needs and concerns is crucial to promoting effective treatment adherence. In summary, low adherence to pharmacological treatment in chronic diseases represents a significant challenge, affecting therapeutic efficacy and patient prognosis. Strategies that consider the complexity of human behavior and personalized approaches are key to improving adherence, resulting in better health outcomes and quality of life for patients affected by chronic diseases. |
id |
GOE-1_527f85116eeff7796cc5f758ff71fc6d |
---|---|
oai_identifier_str |
oai:ojs.bjihs.emnuvens.com.br:article/840 |
network_acronym_str |
GOE-1 |
network_name_str |
Brazilian Journal of Implantology and Health Sciences |
repository_id_str |
|
spelling |
DOENÇAS CRÔNICAS E A BAIXA ADESÃO AO TRATAMENTO FARMACOLÓGICODoença, Tratamento, Farmacológico, Hospital, Pessoas.Chronic diseases represent a significant global health challenge, characterized by their long duration and continuous impact on quality of life. Low adherence to pharmacological treatment is a recurring problem in this context, affecting therapeutic efficacy and disease progression. This lack of adherence can result from several factors, including complexity of the therapeutic regimen, medication side effects, costs, implications and individual perceptions, forgetfulness, or lack of understanding about the importance of treatment. The effects of low adherence are significant, leading to preventable complications, frequent hospitalizations and an increased burden of morbidity and mortality. Strategies to improve adherence to pharmacological treatment, educational interventions, simplification of medication regimens, use of reminders, social support, and regular monitoring by health professionals. The use of technology, such as apps and electronic devices, has also been shown to be helpful in improving adherence. It is essential that there is a multidisciplinary approach to address low adherence to treatment, involving doctors, pharmacists, psychologists, and other health professionals. Furthermore, creating a supportive environment that considers patients' individual needs and concerns is crucial to promoting effective treatment adherence. In summary, low adherence to pharmacological treatment in chronic diseases represents a significant challenge, affecting therapeutic efficacy and patient prognosis. Strategies that consider the complexity of human behavior and personalized approaches are key to improving adherence, resulting in better health outcomes and quality of life for patients affected by chronic diseases.As doenças crônicas representam um desafio significativo para a saúde global, caracterizado por sua longa duração e impacto contínuo na qualidade de vida. A baixa adesão ao tratamento farmacológico é um problema recorrente nesse contexto, afetando a eficácia terapêutica e a progressão da doença. Essa falta de adesão pode resultar de diversos fatores, incluindo complexidade do regime terapêutico, efeitos colaterais dos medicamentos, custos, implicações e percepções individuais, esquecimento ou falta de entendimento sobre a importância do tratamento. Os efeitos da baixa adesão são significativos, levando a complicações evitáveis, hospitalizações frequentes e um aumento da carga de morbidade e mortalidade. Estratégias para melhorar a adesão ao tratamento farmacológico, intervenções educacionais, simplificação dos regimes de medicação, uso de lembretes, apoio social e acompanhamento regular por profissionais de saúde. O emprego de tecnologia, como aplicativos e dispositivos eletrônicos, também foi mostrado útil na melhoria da adesão. É essencial que haja uma abordagem multidisciplinar para enfrentar a baixa adesão ao tratamento, envolvendo médicos, farmacêuticos, psicólogos e outros profissionais de saúde. Além disso, a criação de um ambiente de suporte que leve em consideração as necessidades e preocupações individuais dos pacientes é crucial para promover uma adesão eficaz ao tratamento. Em resumo, a baixa adesão ao tratamento farmacológico em doenças crônicas representa um desafio significativo, afetando a eficácia terapêutica e o prognóstico dos pacientes. Estratégias que consideram a complexidade do comportamento humano e abordagens personalizadas são fundamentais para melhorar a adesão, resultando em mais bem resultados de saúde e qualidade de vida para os pacientes afetados por doenças crônicas.Specialized Dentistry Group2023-11-14info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://bjihs.emnuvens.com.br/bjihs/article/view/84010.36557/2674-8169.2023v5n5p2926-2938Brazilian Journal of Implantology and Health Sciences ; Vol. 5 No. 5 (2023): BJIHS QUALIS B3; 2926-2938Brazilian Journal of Implantology and Health Sciences ; Vol. 5 Núm. 5 (2023): BJIHS QUALIS B3; 2926-2938Brazilian Journal of Implantology and Health Sciences ; v. 5 n. 5 (2023): BJIHS QUALIS B3; 2926-29382674-8169reponame:Brazilian Journal of Implantology and Health Sciencesinstname:Grupo de Odontologia Especializada (GOE)instacron:GOEporhttps://bjihs.emnuvens.com.br/bjihs/article/view/840/984Copyright (c) 2023 Renan Italo Rodrigues Dias, Maria Eduarda de Sá Bonifácio Rocha, Matheus Gomes da Costa, Ítalo Íris Boiba Rodrigues da Cunha, Alessandra Mary Fonseca de Souza Cunha, Bruno Leonardo de Souza Serra, Gleice da Costa Cardoso, Clarice Pereira de Jesus Rodrigues, Ametista de Oliveira Queiroz, Lucilene Nogueira dos Santos Souza, Morgana Albuquerque Prates, Jamilly Lino Marqueshttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccess Dias, Renan Italo Rodrigues Rocha, Maria Eduarda de Sá BonifácioCosta, Matheus Gomes da Cunha, Ítalo Íris Boiba Rodrigues daCunha, Alessandra Mary Fonseca de SouzaSerra, Bruno Leonardo de SouzaCardoso, Gleice da CostaRodrigues, Clarice Pereira de Jesus Queiroz, Ametista de OliveiraSouza, Lucilene Nogueira dos SantosPrates, Morgana AlbuquerqueMarques, Jamilly Lino2023-11-14T16:44:57Zoai:ojs.bjihs.emnuvens.com.br:article/840Revistahttps://bjihs.emnuvens.com.br/bjihsONGhttps://bjihs.emnuvens.com.br/bjihs/oaijournal.bjihs@periodicosbrasil.com.br2674-81692674-8169opendoar:2023-11-14T16:44:57Brazilian Journal of Implantology and Health Sciences - Grupo de Odontologia Especializada (GOE)false |
dc.title.none.fl_str_mv |
DOENÇAS CRÔNICAS E A BAIXA ADESÃO AO TRATAMENTO FARMACOLÓGICO |
title |
DOENÇAS CRÔNICAS E A BAIXA ADESÃO AO TRATAMENTO FARMACOLÓGICO |
spellingShingle |
DOENÇAS CRÔNICAS E A BAIXA ADESÃO AO TRATAMENTO FARMACOLÓGICO Dias, Renan Italo Rodrigues Doença, Tratamento, Farmacológico, Hospital, Pessoas. |
title_short |
DOENÇAS CRÔNICAS E A BAIXA ADESÃO AO TRATAMENTO FARMACOLÓGICO |
title_full |
DOENÇAS CRÔNICAS E A BAIXA ADESÃO AO TRATAMENTO FARMACOLÓGICO |
title_fullStr |
DOENÇAS CRÔNICAS E A BAIXA ADESÃO AO TRATAMENTO FARMACOLÓGICO |
title_full_unstemmed |
DOENÇAS CRÔNICAS E A BAIXA ADESÃO AO TRATAMENTO FARMACOLÓGICO |
title_sort |
DOENÇAS CRÔNICAS E A BAIXA ADESÃO AO TRATAMENTO FARMACOLÓGICO |
author |
Dias, Renan Italo Rodrigues |
author_facet |
Dias, Renan Italo Rodrigues Rocha, Maria Eduarda de Sá Bonifácio Costa, Matheus Gomes da Cunha, Ítalo Íris Boiba Rodrigues da Cunha, Alessandra Mary Fonseca de Souza Serra, Bruno Leonardo de Souza Cardoso, Gleice da Costa Rodrigues, Clarice Pereira de Jesus Queiroz, Ametista de Oliveira Souza, Lucilene Nogueira dos Santos Prates, Morgana Albuquerque Marques, Jamilly Lino |
author_role |
author |
author2 |
Rocha, Maria Eduarda de Sá Bonifácio Costa, Matheus Gomes da Cunha, Ítalo Íris Boiba Rodrigues da Cunha, Alessandra Mary Fonseca de Souza Serra, Bruno Leonardo de Souza Cardoso, Gleice da Costa Rodrigues, Clarice Pereira de Jesus Queiroz, Ametista de Oliveira Souza, Lucilene Nogueira dos Santos Prates, Morgana Albuquerque Marques, Jamilly Lino |
author2_role |
author author author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Dias, Renan Italo Rodrigues Rocha, Maria Eduarda de Sá Bonifácio Costa, Matheus Gomes da Cunha, Ítalo Íris Boiba Rodrigues da Cunha, Alessandra Mary Fonseca de Souza Serra, Bruno Leonardo de Souza Cardoso, Gleice da Costa Rodrigues, Clarice Pereira de Jesus Queiroz, Ametista de Oliveira Souza, Lucilene Nogueira dos Santos Prates, Morgana Albuquerque Marques, Jamilly Lino |
dc.subject.por.fl_str_mv |
Doença, Tratamento, Farmacológico, Hospital, Pessoas. |
topic |
Doença, Tratamento, Farmacológico, Hospital, Pessoas. |
description |
Chronic diseases represent a significant global health challenge, characterized by their long duration and continuous impact on quality of life. Low adherence to pharmacological treatment is a recurring problem in this context, affecting therapeutic efficacy and disease progression. This lack of adherence can result from several factors, including complexity of the therapeutic regimen, medication side effects, costs, implications and individual perceptions, forgetfulness, or lack of understanding about the importance of treatment. The effects of low adherence are significant, leading to preventable complications, frequent hospitalizations and an increased burden of morbidity and mortality. Strategies to improve adherence to pharmacological treatment, educational interventions, simplification of medication regimens, use of reminders, social support, and regular monitoring by health professionals. The use of technology, such as apps and electronic devices, has also been shown to be helpful in improving adherence. It is essential that there is a multidisciplinary approach to address low adherence to treatment, involving doctors, pharmacists, psychologists, and other health professionals. Furthermore, creating a supportive environment that considers patients' individual needs and concerns is crucial to promoting effective treatment adherence. In summary, low adherence to pharmacological treatment in chronic diseases represents a significant challenge, affecting therapeutic efficacy and patient prognosis. Strategies that consider the complexity of human behavior and personalized approaches are key to improving adherence, resulting in better health outcomes and quality of life for patients affected by chronic diseases. |
publishDate |
2023 |
dc.date.none.fl_str_mv |
2023-11-14 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://bjihs.emnuvens.com.br/bjihs/article/view/840 10.36557/2674-8169.2023v5n5p2926-2938 |
url |
https://bjihs.emnuvens.com.br/bjihs/article/view/840 |
identifier_str_mv |
10.36557/2674-8169.2023v5n5p2926-2938 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://bjihs.emnuvens.com.br/bjihs/article/view/840/984 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Specialized Dentistry Group |
publisher.none.fl_str_mv |
Specialized Dentistry Group |
dc.source.none.fl_str_mv |
Brazilian Journal of Implantology and Health Sciences ; Vol. 5 No. 5 (2023): BJIHS QUALIS B3; 2926-2938 Brazilian Journal of Implantology and Health Sciences ; Vol. 5 Núm. 5 (2023): BJIHS QUALIS B3; 2926-2938 Brazilian Journal of Implantology and Health Sciences ; v. 5 n. 5 (2023): BJIHS QUALIS B3; 2926-2938 2674-8169 reponame:Brazilian Journal of Implantology and Health Sciences instname:Grupo de Odontologia Especializada (GOE) instacron:GOE |
instname_str |
Grupo de Odontologia Especializada (GOE) |
instacron_str |
GOE |
institution |
GOE |
reponame_str |
Brazilian Journal of Implantology and Health Sciences |
collection |
Brazilian Journal of Implantology and Health Sciences |
repository.name.fl_str_mv |
Brazilian Journal of Implantology and Health Sciences - Grupo de Odontologia Especializada (GOE) |
repository.mail.fl_str_mv |
journal.bjihs@periodicosbrasil.com.br |
_version_ |
1796798441045622784 |